drugset / Trial / NCT07616544

Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization

NCT07616544 ↗

Phase 3 Not yet recruiting 164 enrolled Liu Qiang
RandomizedParallel-groupTriple-blindTreatment

Summary

1. Evaluate the efficacy and safety of Qidan Xiaohe granules in patients after coronary revascularization surgery; 2. Develop a traditional Chinese medicine rehabilitation treatment plan and evaluation system for the use of Qidan Xiaohe granules after coronary revascularization surgery; 3. Demonstrate the advantages of traditional Chinese medicine rehabilitation treatment in the postoperative management of coronary revascularization surgery and provide high-level evidence-based medical evidence for the development of traditional Chinese medicine rehabilitation treatment plans.

Timeline

Start
2026-07-01
Primary completion
2028-06-30
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Qidan Xiaoke Granules Traditional medicine (herbal / TCM) 1 unknown Oral